market perceiv
ow el potenti short/long-term top-line upsid
vs consensu driven conserv el guidanc short-
term well long-term analysi around el mix shift
favor geographies/channel
el favor market perceiv este stock
weaken around ep close day ep although
acknowledg stock week lead result note
address concern believ overblown explain
see support ow rate top pick order coverag
ko beverag pg hpc food el
inform pleas see recent review ko pg
address key point think market misread el result
point convict top-line upsid risen investor
voic concern el top-line outlook lower guidanc
prestig beauti categori growth percept
worsen extern macro trend believ visibl upsid increas
post highlight key point el top-line visibl strong momentum
sustain above-consensu average organ sale growth
similar last two quarter guidanc impli unrealist
slowdown back half year impli deceler average
growth vs even assum el meet high end
rang use forecast see key extern
risk factor lower dissip risk china trade issu clariti
result china trade issu spread asian region
point ep visibl higher perceiv addit
top-line concern believ also rais misguid concern around ep
visibl follow el lower ep guidanc report basi
slightli rais fx-neutral ep guidanc highlight reason
comfort above-consensu ep estim mse vs
consensu top-line visibl remain high previous mention
impli increment margin balanc year appear
conserv balanc year fx-adjust basi vs
household person unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
share repurchas step el repurchas
share share price current level fx assumpt built
el guidanc appear conserv comparison current spot rate
embed eur vs current embed gbp vs current
point corpor mix shift higher growth geograph segment
sale upsid driven upsid el momentum geographi asia
bp ahead consensu emea bp bode well futur
growth mix shift higher margin area assum similar growth
rate region vs mix shift alon would drive favor
bp greater top-line growth
point el valuat remain compel el top-line outpac
peer increasingli wider margin last year el gap vs
european prestig beauti growth bp
el gap hpc growth similarli expand bp
bp yet el ntm price-to-earnings premium peer remain line
histor level consid unfair given see el clearli
high growth potenti fulli price valuat
high growth potenti fulli price valuat
line base case assumpt
top-line margin upsid revenu upsid travel retail bp
price drive top-line upsid lt forecast el also deliv
cost-cut upsid valuat expand buoy
peer-lead topline/ep growth e-commerc china travel retail drive
strong organ revenu growth lt top-line growth cost-cut
top-line leverag drive annual underli margin expans bps/year
appli ebitda multipl
top-line slowdown top-line miss china slowdown travel retail
miss bp global impact weaker macro valuat contract
organ sale growth re-acceler
ldd rang well cpg
peer lsd rang growth gap
widen recent quarter view el
top-line out-performance sustain long
term albeit lesser magnitud strong
high growth area travel retail
e-commerc el
disproportion exposur increas
mix el busi rapidli expand
emerg market us specialti channel
low given much higher topline/ep
growth potenti long-term basi
risk achiev price
risk includ china result slow
price unfavor fx
valu
exhibit bear bull driver travel retail cost-cut
sid
el top-line momentum continu encourag continu
strong top-line result el post yoy organ sale growth
consensu importantli averag organ sale growth
third straight quarter record crisi level result deceler
slightli unround basi average vs
attribut slight deceler hong kong rest
busi maintain momentum
exhibit sustain strong el average organ sale growth
 guidanc impli unrealist slowdown back half year
view el impli guidanc conserv give us confid fy upsid
least result high-end guidanc appli bp top-line beat
guidanc vs midpoint el guidanc given el beaten midpoint
quarterli organ sale growth guidanc bp averag last
quarter basi use high end el guidanc rang el
would need post impli slowdown organ sale growth
vs last quarter hit high-end fy guidanc seem
conserv see chart
exhibit el consist beaten quarterli guidanc wide margin histor
 extern risk factor lessen believ investor perceiv extern
macro worsen el past month somewhat support even
el call commentari surfac look clear macro uncertainti
increas uk brexit concern hong kong unrest continu us
depart store struggl persist point minor
macro concern affect el key one china well hong kong
allevi creat less overal risk give detail two biggest risk
factor mind includ potenti consum avers el product
china sale includ travel retail given china import
drive el growth look like less risk today three month ago given
progress trade talk acknowledg trade situat still uncertain
think fact progress made talk materi lower
probabl unfavor scenario around trade second big risk factor
materi worsen consum demand asia yoy hong kong sale
declin clearli neg manag given hong kong
sale mix bp corpor organ sale growth impact el
post organ sale growth el indic call lower hong
sale gener shift elsewher region make adjust within
hong kong away tourist area mitig top-line pressur within hong kong go
forward given appar lower probabl tail unfavor impact
two key risk factor less concern higher macro risk less
import area macro situat uk sale
point higher ep visibl perceiv
top line momentum visibl remain strong prior discuss
point top-line guidanc look conserv
 impli increment margin balanc year also look conserv
top-line guidanc see balanc year margin upsid increment oper
profit margin use mse consensu fx-adjust basi
balanc year
exhibit impli increment margin balanc year look conserv
balanc year
 repurchas step expect el remain aggress go
forward rais estim el share repurchas balanc year
cumul share repurchas contribut
ep accret ep estim see room upsid expect el
aggress repurchas share consid current share price
el averag repurchas price repurchas share
el balanc sheet strong posit net debt/fi ebitda
exhibit expect el repurchas
revis guidanc incorpor fx spot rate septemb
remain three quarter year eur gbp cni
appear conserv consid current spot rate eur gbp cni
view anoth potenti sourc upsid guidanc balanc
year
exhibit el guidanc appear emb conservat fx assumpt recent usd
assum el guidanc
point favor geograph mix increas magnitud
geograph mix tailwind build anoth reason encourag us
top-line upsid driven el higher growth segment emea asia pacif
secondarili also higher margin drive even greater profit upsid report revenu
beat consensu bp emea bp asia pacif
key region growth momentum thu import el forward result
vs larg bp revenu miss lower growth lower margin america region
thu composit result favor futur corpor growth potenti
exhibit top-line upsid driven el higher growth segment emea/asia pacif
el top-line upsid vs consensu
el geograph mix continu shift favor discuss
composit result favor upsid higher growth higher margin
area emea asia quantifi mix shift higher growth
area mean time base histor growth rate geograph area includ
increment bp benefit top-line one use similar growth rate
revenu profit increas
exhibit el geograph mix skew toward higher growth
region emea asia pacif vs weaker america region
el profit mix geographi
el top-line growth increasingli outpac peer reflect similar
rel valuat el organ sale growth outperform prestig beauti
hpc peer increasingli wide margin recent year el gap organ sale
growth vs prestig beauti peer expand bp bp
bp bp el gap vs hpc peer expand
bp bp bp bp
howev el ntm price-to-earnings premium remain line averag
prestig beauti hpc peer set seem unfair given much greater rel
exhibit given significantli higher growth el
prestig beauti peer includ oreal beiersdorf refinitiv morgan stanley research
prestig beauti peer includ oreal beiersdorf compani data morgan stanley research
exhibit rel hpc peer el valuat seem
exhibit despit steep acceler org sale growth gap
valuat methodolog risk
pt forecast organ sale growth go forward hpc
peer led improv us result build market share momentum better price
realiz continu cost save support bp om expansion/yr drive
hsd ep growth appli multipl ep slight premium pg
market share vacil currenc commod volatil
pt organ top-line growth ebit growth organ sale
growth beyond om bp annual top-line growth
price cost save valuat expand ep impli
downsid risk volum recoveri lower price weaker price due lower
inflat em volum pressur categori weaker margin expans
higher reinvest dissip strateg potenti
upsid risk greater strateg potenti rebound volume/market share
pt forecast organ top-line growth hsd ep growth
beyond appli price-to-earnings multipl base case ep cpg
peer driven strong price power ko transform higher growth/roic
concentr model bottl divestitur posit chang new
health well pressur lower expect product soda tax
pt organ sale growth driven solid snack growth
om expand bp annual post reinvest cost save assum
price-to-earnings lt histori reflect higher top-line growth visibl
in-lin multipl mega-cap cpg peer
risk includ russia/mexico/china volatil commod cost fx volatil lower
expect cost save restructur acceler competit intens
beverag soda tax macro and/or health-rel top-line weak
